Blätt­chen & Part­ner advi­ses The Manage­ment of Phar­ma­Zell on the sale to Bridge­point

Inter­na­tio­nal pri­va­te equi­ty inves­tor Bridge­point acqui­res a majo­ri­ty sta­ke in Phar­ma­Zell from DPE Deut­sche Pri­va­te Equi­ty and Max­burg Capi­tal Part­ners. The par­ties have agreed not to dis­c­lo­se the purcha­se pri­ce.

Phar­ma­Zell is a lea­ding inde­pen­dent manu­fac­tu­rer of phar­maceu­ti­cal acti­ve ingre­di­ents (API) in the high­ly sta­ble and spe­cia­li­zed API mar­ket. The com­pa­ny has a diver­si­fied port­fo­lio of more than 70 acti­ve ingre­di­ents and holds a lea­ding posi­ti­on in the indus­try of pro­ducts for the tre­at­ment of respi­ra­to­ry, inflamm­a­to­ry and liver dise­a­ses, which are favor­ed by chan­ging life­styl­es. Many of the com­pany’s pro­ducts requi­re spe­cial tre­at­ment pro­ce­du­res and/or tech­no­lo­gies. Phar­ma­Zell, head­quar­te­red in Raub­ling (near Munich), ope­ra­tes four sta­te-of-the-art pro­duc­tion and R&D loca­ti­ons in Ger­ma­ny, Ita­ly and India and employs more than 900 peo­p­le world­wi­de.

Bridge­point mana­ges over 29 bil­li­on euros, which are pro­vi­ded by glo­bal inves­tors. The­se include public and pri­va­te pen­si­on funds, asset mana­gers, fami­ly offices, inde­pen­dent aut­ho­ri­ties and insu­rance com­pa­nies around the world.

Blätt­chen & Part­ner advi­sed the manage­ment of Phar­ma­Zell as part of the sale with Prof. Dr. Alex­an­der Götz.

About Blätt­chen & Part­ner

Blätt­chen & Part­ner regu­lar­ly advi­ses manage­ment teams from a wide ran­ge of com­pa­nies and indus­tries and has more than 20 years of exper­ti­se in advi­sing and imple­men­ting manage­ment and employee par­ti­ci­pa­ti­on pro­grams.

With inno­va­ti­ve finan­cial stra­te­gies, Blätt­chen & Part­ner GmbH has been one of the lea­ding cor­po­ra­te finan­ce experts in Ger­ma­ny for more than 30 years. The Munich-based com­pa­ny spe­cia­li­ses in advi­sing on manage­ment par­ti­ci­pa­ti­on programmes,IPOs, bonds, pro­mis­so­ry note loans and the asso­cia­ted capi­tal mar­ket sup­port after the issue. Other are­as of focus in the ran­ge of ser­vices are com­pa­ny invest­ments and M&A tran­sac­tions. More than 500 tran­sac­tions are a tes­ta­ment to the com­pany’s pro­ven exper­ti­se. The gro­wing inter­di­sci­pli­na­ry com­pe­tence net­work, the high level of cus­to­mer satis­fac­tion and the lar­ge num­ber of publi­ca­ti­ons on important cor­po­ra­te finan­ce topics reflect the reco­g­nis­ed repu­ta­ti­on of Blätt­chen & Part­ner GmbH.

Press release as .pdf